PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 152 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $629,000 | -25.3% | 165,500 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $842,000 | +4.7% | 165,500 | +4.0% | 0.00% | 0.0% |
| Q3 2019 | $804,000 | -15.5% | 159,100 | +3.2% | 0.00% | 0.0% |
| Q2 2019 | $951,000 | +33.0% | 154,100 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $715,000 | +15.5% | 154,100 | +4.5% | 0.00% | 0.0% |
| Q4 2018 | $619,000 | -33.0% | 147,400 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $924,000 | -6.1% | 147,400 | +20.4% | 0.00% | 0.0% |
| Q2 2018 | $984,000 | +7.8% | 122,400 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $913,000 | +32.7% | 122,400 | +5.8% | 0.00% | 0.0% |
| Q4 2017 | $688,000 | -19.2% | 115,700 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $852,000 | +8.4% | 115,700 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $786,000 | -28.0% | 115,700 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,092,000 | +9.2% | 115,700 | 0.0% | 0.00% | -50.0% |
| Q4 2016 | $1,000,000 | +36.6% | 115,700 | 0.0% | 0.00% | +100.0% |
| Q3 2016 | $732,000 | +50.0% | 115,700 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $488,000 | +0.2% | 115,700 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $487,000 | -15.9% | 115,700 | +22.4% | 0.00% | 0.0% |
| Q4 2015 | $579,000 | +7.0% | 94,500 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $541,000 | -12.5% | 94,500 | +14.1% | 0.00% | -50.0% |
| Q2 2015 | $618,000 | – | 82,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|